add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Admin error forces GSK to withdraw Avodart prostate cancer sNDAPharma Times - - Nov 24, 2009 GlaxoSmithKline has withdrawn a supplemental New Drug Application in the USA for its benign prostatic hyperplasia treatment Avodart though the move is not ... Coexistence of pernicious anemia and prostate cancer - 'an experiment of ...7thSpace Interactive (press release) - Nov 24, 2009 IntroductionThis report presents the clinical and laboratory course of a patient with prostate cancer and severe vitamin B12 deficiency undergoing watchful ... Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, UnilifeSeeking Alpha (blog) - - Nov 25, 2009 Nymox's New Trial For Benign Prostatic Hyperplasia Drug Records Positive ...RTT News - Nov 23, 2009 ... US Phase 2 studies of NX-1207 indicated positive data from responder analysis, the new clinical trial for benign prostatic hyperplasia or BPH. ... Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for ... CNNMoney.com (press release) Smoking Increases Risk of Fatal Prostate CancerRenal and Urology News - - Nov 23, 2009 Recent cigarette smoking is associated with an increased risk of fatal prostate cancer, according to a new report. Sheila Weinmann, PhD, of the Center for ... Prostate-Sparing Cystectomy Is SafeRenal and Urology News - - Nov 23, 2009 Prostate-sparing cystectomy (PSC) for bladder cancer, a procedure aimed at preserving sexual function by leaving the prostate, seminal vesicles, ... Below the beltNational - - Nov 22, 2009 A non-cancerous condition called BPH (benign prostatic hyperplasia) is far more common, affecting up to four in 10 men over 65. ... GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug ...Reuters - Nov 2, 2009 GTx is pursuing marketing approval in the United States for toremifene 80 mg to reduce fractures in men with prostate cancer on ADT. ... Dendreon Completes Submission of Biologics License Application for PROVENGEReuters - Nov 2, 2009 The amended BLA includes data from the IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) trial, which was conducted under a Special Protocol ... Finasteride and the Risk of Prostate CancerMedpie.com (blog) - - Nov 13, 2009 But some follow up studies and commentary were available, and the picture is not somewhat more nuanced: the Prostate Cancer Prevention Trial demonstrated ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
